Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 2/20 | 0.46 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.46 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.46 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | F7 | P08709 | 1/20 | 0.46 |
| ▸ | F3 | P13726 | 1/20 | 0.46 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.46 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.46 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL19057041 | 0.96 | PI4KA (0.44) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL1408059 | 0.94 | PI4KA (0.50) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL27528672 | 0.94 | PI4KA (0.50) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL15700 | 0.91 | PI4KA (0.55) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL22748487 | 0.91 | PI4KA (0.55) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL2564210 | 0.91 | PI4KA (0.55) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL23531102 | 0.90 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL11807683 | 0.90 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL1324561 | 0.90 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL7712108 | 0.90 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512486-B2 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2023-07-12 | — | — | EP | claimed |
| EP-3512486-B1 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2020-10-21 | — | — | EP | claimed |
| EP-3512486-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'Oreal (FR) | 2019-07-24 | — | — | EP | claimed |
| WO-2018050504-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'OREAL (FR) | 2018-03-22 | — | — | WO | claimed |
| US-6750038-B1 | Rapid antibiotic susceptibility test | ESSENTIAL THERAPEUTICS, INC. | 2004-06-15 | — | — | US | claimed |
| US-5460830-A | Biochemically active agents for chemical catalysis and cell receptor activation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-24 | — | — | US | claimed |
| US-5460831-A | Targeted transfection nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-24 | — | — | US | claimed |
| EP-3512486-B2 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2023-07-12 | — | — | EP | disclosed |
| CN-114796107-A | Tobramycin sulfate injection containing nicotinide diphosphate and preparation method thereof | 西藏邦臣药业集团有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-107428744-B | Novel heterocyclic compounds and their use in medicine and cosmetics | 盖尔德马研究及发展公司 | 2021-09-24 | — | — | CN | disclosed |
| EP-3512486-B1 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2020-10-21 | — | — | EP | disclosed |
| CN-110621304-A | Combination of active ingredients, composition comprising the same and use thereof in the treatment of sarcopenia | 阿法玛公司 | 2019-12-27 | — | — | CN | disclosed |
| EP-3512486-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'Oreal (FR) | 2019-07-24 | — | — | EP | disclosed |
| EP-0726767-A1 | BIOCHEMICALLY ACTIVE AGENTS FOR CHEMICAL CATALYSIS AND CELL RECEPTOR ACTIVATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-08-21 | — | — | EP | disclosed |
| US-5506420-A | PREVENT DENATURIZATION OF ELECTRONICALLY ACTIVE BIOCHEMICAL MOLECULE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-04-09 | — | — | US | disclosed |
| US-5462751-A | Biological and pharmaceutical agents having a nanomeric biodegradable core | THE REGEANTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-31 | — | — | US | disclosed |
| US-5460830-A | Biochemically active agents for chemical catalysis and cell receptor activation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-24 | — | — | US | disclosed |
| US-5460831-A | Targeted transfection nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-24 | — | — | US | disclosed |
| WO-1995018234-A1 | METHOD FOR ENZYMATICALLY ASSAYING CREATININE OR THE AMMONIUM ION AND REAGENT KIT FOR CARRYING OUT SAID METHOD | PASTEUR SANOFI DIAGNOSTICS (FR) | 1995-07-06 | — | — | WO | disclosed |
| WO-1995012392-A1 | BIOCHEMICALLY ACTIVE AGENTS FOR CHEMICAL CATALYSIS AND CELL RECEPTOR ACTIVATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-05-11 | — | — | WO | disclosed |